FDA Adverse Event Death Summary report: N

CARDIVA MEDICAL INC. VASCADE MVP VCS

MDR report key: 9832773 · Received March 14, 2020

Report

Report Number
3004182619-2020-00006
Event Type
Death
Date Received
March 14, 2020
Date of Event
February 14, 2020
Report Date
March 13, 2020
Manufacturer
CARDIVA MEDICAL, INC.
Product Code
MGB
PMA / PMN Number
P120016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PER THE INITIAL REPORT, THE VASCADE MVP DEVICE PERFORMED PER SPECIFICATIONS. THE DEVICE WAS NOT RETURNED FOR PHYSICAL INVESTIGATION. THE COMPLAINT REPORTS AN INFECTION. THERE IS NO REPORT OF DEVICE MALFUNCTION AND ALL DEVICES ARE STERILIZED THROUGH VALIDATED METHOD AND STERILIZATION CERTIFICATE IS ON FILE FOR ALL LOTS OF DEVICES.

Description of Event or Problem · 1

THE PATIENT HAD 4 ACCESS SITES THAT ALL UTILIZED THE VASCADE MVP DEVICE FOR CLOSURE. ALL 4 OF THE DEPLOYMENTS WENT WELL AND FINAL HEMOSTASIS WAS ACHIEVED WITH THE VASCADE MVP DEVICES. ONE OF THE SITES DEVELOPED A 4 CM X 4 CM HEMATOMA WHICH WAS PRESSED OUT. THE NEXT DAY PATIENT DEVELOPED NECROTIZING FASCIITIS AND A FASCIOTOMY WAS PERFORMED. PATIENT BECAME SEPTIC. IT IS NOTED THAT PATIENT HAD A HISTORY OF PERIPHERAL VASCULAR DISEASE, BUT THE DOCTOR DID NOT HAVE ISSUE GAINING ACCESS TO THE VEINS. ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2020: PATIENT PASSED AWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
296205 CARDIVA MEDICAL INC. VASCADE MVP VCS VASCADE MVP MGB CARDIVA MEDICAL, INC. 800-612C UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 70 YR Death